吃瓜不打烊

Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Healthcare Helpline
    • 吃瓜不打烊 Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • Common Ground
    • Diagnosis: Debt
    • The Body Shops
    • Priced Out
    • Guns, Race, and Profit
    • Broken Rehab
    • Dead Zone
    • Denied
    • Opioid Settlement Tracking
    • Eleven Minutes
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Healthcare Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health
    All Topics

  • Medicare Advantage Billing Probe
  • School Vaccine Mandates
  • Weight Loss Drugs Coverage
  • Opioid Settlement Money
  • Abortion Pill Access

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Friday, Dec 1 2017

Full Issue

Potential $66B Deal For CVS To Buy Aetna Would Create Mammoth Health Care Company

CVS Health Corp. may pay $200 to $205 per share to acquire Aetna Inc., the Wall Street Journal reports, but the deal isn鈥檛 final yet. In other industry news, Express Scripts' CEO says the company isn't shopping for its own insurer deal but is open to the idea, as well as partnering with Amazon.

CVS Health Corp. is moving closer to a deal to buy Aetna Inc. for more than $66 billion in cash and stock. The deal, which could be announced by Monday, would create a health-care behemoth selling everything from drugs to insurance. The companies are in advanced stages of negotiating a deal, according to people familiar with the matter. It would likely be valued at between $200 and $205 per Aetna share and consist mainly of cash, some of the people said. (Mattioli and Wilde Mathews, 11/30)

CVS Health Corp.聽is nearing an agreement to acquire health insurer聽Aetna Inc.聽for more than $65 billion, according to a person familiar with the negotiations, in a deal that could reshape the pharmacy and health insurance industries.聽An announcement could come as soon as Monday, said the person, who asked not to be identified because the talks are private. CVS is likely to agree to pay at least $200 a share for Aetna, with more than 30 percent paid for with cash, according to the person. Talks could still be delayed or fall apart. (Langreth and Tracer, 11/30)

Express Scripts Holding Co.鈥檚 chief executive said he鈥檚 open to a deal with a health insurer or partnering with Amazon.com Inc.聽CEO Tim Wentworth鈥檚 pharmacy benefits company has been battered by departing clients and the vague specter of Amazon鈥檚 entry into the drug business.聽If a major insurer was interested in a deal, 鈥淚 would be open to it,鈥 Wentworth said on the sidelines of a conference聽in New York sponsored by Forbes. 鈥淲e don鈥檛 need to sell to be very successful in the future, but we are always open to others who may all of sudden conclude they want what we have.鈥 (Langreth, 11/30)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, August 5
  • Tuesday, August 4
  • Monday, August 3
  • Friday, July 31
  • Thursday, July 30
  • Wednesday, July 29
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • 吃瓜不打烊
  • Republish Our Content
  • Contact Us

Follow Us

  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

漏 2026 KFF